Objective: To assess the safety and efficacy of ultrasonographic vs. fluoroscopic access for percutaneous nephrolithotomy (PCNL). Methods: Medline (PubMed), Embase, Ovid, Cochrane, and the Chinese Biomedical Literature databases were searched to identify clinically controlled trials (CCTs) and randomized controlled trials (RCTs) that compared ultrasonographic access with fluoroscopic access for PCNL. RevMan 5.1 software and Stat Manager V4.1 software were used for the meta-analysis. Results: Five RCTs and nine CCTs were included in our study, which contained a total of 3,019 patients. Of these, 1,574 (52%) had undergone ultrasonographic access, and 1,445 (48%) had undergone fluoroscopic access. The pooled results revealed that the ultrasonographic access patients had shorter duration of access (min) by 2.56 min (weighted mean difference (WMD) = −2.56, 95% confidence interval (CI): −4.40 to −0.72, p = 0.006). There was a higher stone-free rate in the ultrasonographic access group (odds ratio (OR) = 1.26, 95% CI: 1.02-1.55, p = 0.03), as well as a lower rate of operative complications (OR = 0.72, 95% CI: 0.56-0.93, p = 0.01), reduced intraoperative blood loss (ml) (WMD = −14.55 ml, 95% CI: −27.65 to −1.46, p = 0.03), and a lower rate of blood transfusion requirement (OR = 0.39, 95% CI: 0.24-0.63, p = 0.0001). Sensitivity and subgroup analyses were also performed. Conclusion: Except for no radiation exposure, our meta-analysis revealed that ultrasonographic access had many advantages, such as a shorter access time, reduced intraoperative blood loss, a lower rate of operative complications, a lower rate of blood transfusion, and a higher stone-free rate. Because of these significant advantages, we recommend the use of ultrasonographic access for PCNL.

Keywords:
Fluoroscopic, Nephrolithotomy, Percutaneous, PCNL, Ultrasonographic
1.
Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, Parvin M, Basiri A: Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis 2014;63:456-463.
2.
Lieske JC: New insights regarding the interrelationship of obesity, diet, physical activity, and kidney stones. J Am Soc Nephrol 2014;25:211-212.
3.
Kmiecik J, Kucharska E, Sulowicz W, Ochmanski W: [Diagnosis [,]prophylaxis and treatment of urolithiasis]. Przegl Lek 1997;54:335-343.
4.
Haroon N, Nazim SM, Ather MH: Optimal management of lower polar calyceal stone 15 to 20 mm. Korean J Urol 2013;54:258-262.
5.
Fernstrom I, Johansson B: Percutaneous pyelolithotomy. A new extraction technique. ScandJ Urol Nephrol 1976;10:257-259.
6.
Osman M, Wendt-Nordahl G, Heger K, Michel MS, Alken P, Knoll T: Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int 2005;96:875-878.
7.
Saxby MF, Sorahan T, Slaney P, Coppinger SW: A case-control study of percutaneous nephrolithotomy versus extracorporeal shock wave lithotripsy. Br J Urol 1997;79:317-323.
8.
Srivastava A, Chipde SS: Management of 1-2 cm renal stones. Indian J Urol 2013;29:195-199.
9.
Kader AK, Finelli A, Honey RJ: Nephroureterostomy-drained percutaneous nephrolithotomy: modification combining safety with decreased morbidity. J Endourol 2004;18:29-32.
10.
Irby PB, Schwartz BF, Stoller ML: Percutaneous access techniques in renal surgery. Tech Urol 1999;5:29-39.
11.
Miller NL, Matlaga BR, Lingeman JE: Techniques for fluoroscopic percutaneous renal access. J Urol 2007;178:15-23.
12.
Ritter M, Krombach P, Martinschek A, Siegel FP, Schmitt M, Weiss C, Hacker A, Pelzer AE: Radiation exposure during endourologic procedures using over-the-table fluoroscopy sources. J Endourol 2012;26:47-51.
13.
Frede T, Hatzinger M, Rassweiler J: Ultrasound in endourology. J Endourol 2001;15:3-16.
14.
Clarke M, Horton R: Bringing it all together: lancet-cochrane collaborate on systematic reviews. Lancet 2001;357:1728.
15.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
16.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
17.
Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
18.
Athanasiou T, Al-Ruzzeh S, Kumar P, Crossman MC, Amrani M, Pepper JR, Del Stanbridge R, Casula R, Glenville B: Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients. Ann Thorac Surg 2004;77:745-753.
19.
Binbay M, Akman T, Ozgor F, Yazici O, Sari E, Erbin A, Kezer C, Sarilar O, Berberoglu Y, Muslumanoglu AY: Does pelvicaliceal system anatomy affect success of percutaneous nephrolithotomy? Urology 2011;78:733-737.
20.
Oliveira-Santos T, Peterhans M, Roth B, Reyes M, Nolte LP, Thalmann G, Weber S: Computer aided surgery for percutaneous nephrolithotomy: clinical requirement analysis and system design. Conf Proc IEEE Eng Med Biol Soc 2010;2010:442-445.
21.
Akman T, Binbay M, Sari E, Yuruk E, Tepeler A, Akcay M, Muslumanoglu AY, Tefekli A: Factors affecting bleeding during percutaneous nephrolithotomy: single surgeon experience. J Endourol 2011;25:327-333.
22.
Rudnick DM, Stoller ML: Complications of percutaneous nephrostolithotomy. Can J Urol 1999;6:872-875.
23.
Yamaguchi A, Skolarikos A, Buchholz NP, Chomon GB, Grasso M, Saba P, Nakada S, de la Rosette J; Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Study Group: Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study. J Endourol 2011;25:933-939.
24.
Zegel HG, Pollack HM, Banner MC, Goldberg BB, Arger PH, Mulhern C, Kurtz A, Dubbins P, Coleman B, Koolpe H: Percutaneous nephrostomy: comparison of sonographic and fluoroscopic guidance. AJR Am J Roentgenol 1981;137:925-927.
25.
Kukreja R, Desai M, Patel S, Bapat S, Desai M: Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 2004;18:715-722.
26.
Rao PN, Faulkner K, Sweeney JK, Asbury DL, Sambrook P, Blacklock NJ: Radiation dose to patient and staff during percutaneous nephrostolithotomy. Br J Urol 1987;59:508-512.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.